← Back to Clinical Trials
Recruiting NCT05854303
Effect of Opioid Cessation on Opioid-Induced Esophageal Dysfunction
Trial Parameters
Condition Opioid-Induced Esophageal Dysfunction
Sponsor Mayo Clinic
Study Type OBSERVATIONAL
Phase N/A
Enrollment 26
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-09-18
Completion 2026-11
Interventions
Opioid cessationNo opioid cessation
Brief Summary
The purpose of this study is to evaluate the effect of opioid cessation on opioid-induced esophageal dysfunction (OIED).
Eligibility Criteria
Inclusion Criteria: \- Patients enrolled in the Pain Rehabilitation Center for opioid cessation, with or without esophageal symptoms. Exclusion Criteria: * Inability to provide informed consent. * Patients with previous gastroesophageal surgery or pneumatic dilation. * Esophageal botulinum toxin injection within the prior 12 months. * Esophageal stricture * Achalasia types I and II * Allergy to Lidocaine or other local anesthetics * Subjects on anticoagulation * Bilateral nasal obstruction * Pregnancy or breast feeding